Control of severe predominantly eosinophilic asthma with the use of anti IL-5. Rev Alerg Mex [Internet]. 2023 Aug. 21 [cited 2026 Sep. 23];70(3):199. Available from: https://www.revistaalergia.mx/ojs/index.php/ram/article/view/1269